Khiron Life Sciences ist ein kanadisches medizinisches Cannabisunternehmen mit Kernaktivitäten in Kolumbien. Khiron kombiniert führende internationale wissenschaftliche Expertise als auch landwirtschaftliche Vorteile und Markteintrittserfahrung mit Markenprodukten, um die ungedeckten medizinischen Bedürfnisse in einem Markt von über 620 Millionen Menschen in Lateinamerika zu adressieren. Khiron hat in Kolumbien Lizenzen für Cannabis mit hohem und niedrigem Tetrahydrocannabinolanteilen (THC) erhalten und erhält nun alle Lizenzen für den Anbau, die Produktion, den inländischen Vertrieb und den internationalen Export von medizinischem Cannabis sowohl THC als auch Cannabidiol (CBD).
Chief Executive Officer and Director
Mr. Torres has over 15 years of experience in the Latin American market, including infrastructure projects and project finance, management strategy, team development, and mergers and acquisitions. Mr. Torres was previously head of business development for SNC-Lavalin, Colombia, and was instrumental in growing the company from two people to more than 2,000 people in Colombia over the course of three years. Mr. Torres has overseen the development of projects totaling over $1 billion in capital expenditure, including the development and construction of Colombia’s tallest skyscraper. Mr. Torres holds a Bachelor of Engineering and a Masters of Engineering from Rensselaer Polytechnic Institute and an MBA from Georgetown University.
Chief Financial Officer
Mr. Collins is a financial professional focused on the financial development of growth companies globally. He has been involved in over a billion dollars of transactions, and his expertise spans mergers and acquisitions, debt and equity financings, go-public transactions, commercial partnerships, capital budgeting and financial accounting. Prior to his current activities, Mr. Collins was engaged by investment and merchant banks, including Alegro Capital, LP in London, England, and Scotia Capital Inc. and Quest Capital Corp. (currently Sprott Resource Lending Corp.) in Toronto, Canada. In addition, he was previously Chief Financial Officer of an e-commerce company focused on the global distribution of vaporizers and accessories. Mr. Collins holds a Bachelor of Commerce degree in finance from Dalhousie University.
Juan Diego Alvarez
Vice President of Regulations
Mr. Alvarez has 10 years of legal experience in Colombia and is an authority on Colombian medicinal cannabis regulation. He was previously a public policy advisor to the Ministry of Health in Colombia. In the last five years, Mr. Alvarez has been a consultant for Payson Center for International Development and USAID, a Professor of Law at the University of Los Andes, and Chief Regulatory Officer of Khiron Life Sciences Corp. Mr. Alvarez holds an LL.B from the University of Los Andes, a JD from Tulane University, an LL.M from Columbia University and is a PhD law candidate.
Vice President of Commercial
Andrés Galofre has 15 years of experience in pharmaceutical marketing, brand management and distribution of prescription drugs and consumer products in Latin America. Mr. Galofre was integral in leading the launch of Advil in the Colombian market, which reached a 28% domestic market share. In the last five years, Mr. Galofre has been Marketing Manager for Alpina, Founder of VeggiesBox and Chief Commercial Officer of Khiron Life Sciences Corp. Mr. Galofre has a Bachelor of Business Administration from CESA and an MBA from La Trobe University.
Vice President of Compliance
Mr. Murphy is an executive leader with broad based domestic and international expertise in both the federal and private sectors. As a Career Special Agent (25 years) with the DEA, he served in a multitude of positions prior to founding the Pharma Compliance Group (PCG). Mr. Murphy is an internationally recognized security expert in the fields of drug law enforcement, risk assessment and system development, regulatory compliance, and training. Mr. Murphy will support the Company by implementing closed loop systems to prevent product diversion and to enhance protocols across Khiron's plant to patient value chain.
Vice President of Operations
Mr. Orbegozo has over 18 years of experience in pharmaceutical operations and supply chain in Latin America with multinational pharmaceutical companies. His experience includes leading operations, sales & marketing, quality & controls, and GMP, ISO 9001, ISO 14001, and ISO 17025 implementation processes. Mr. Orbegozo holds a B.Eng in Mechanical Engineering and an MBA from Universidad de La Salle, as well as an Advanced Management Program in Innovation from Thunderbird University.
Vice President of Medical
Dr. Vega has 25 years of experience as a neurologist and specific experience in the validation studies approval process at INVIMA, the Colombian drug regulator. Dr. Vega holds an MD from the University of Rosario and an MBA from Deusto Business School.
Dr. Vega will be an independent contractor responsible for leading all efforts in engaging the medical community and validation of Khiron´s products with the medical authorities and will devote 50% of his time to the management of the Resulting Issuer. In the last five years, Dr. Vega has been Immunology Commercial Director for Abbott, Immunology Commercial Director and Medical Director for LA Region North for AbbVie, Head of Neurology for CISNE Group and Business Development and Institutional Market Strategy Director for Biopas Group.